Selected research
Market Analysis & Forecast
Global EO Residual Testing Market Analysis and Forecast 2026-2032
Market perspective
The global EO Residual Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for EO Residual Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for EO Residual Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for EO Residual Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for EO Residual Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of EO Residual Testing include Eurofins Scientific, Nelson Labs, Steris, JordiLabs, LLC, TÜV SÜD, UFAG LABORATORIEN AG, Europejski Instytut Biomedyczny, SaniChem and Millstone Medical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for EO Residual Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of EO Residual Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for EO Residual Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the EO Residual Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global EO Residual Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for EO Residual Testing revenue, projected growth trends, production technology, application and end-user industry.
EO Residual Testing Segment by Company
Eurofins Scientific
Nelson Labs
Steris
JordiLabs, LLC
TÜV SÜD
UFAG LABORATORIEN AG
Europejski Instytut Biomedyczny
SaniChem
Millstone Medical
Medistri
Auriga Research
Pace Analytical
STEMart
MCI
EO Residual Testing Segment by Type
Brief Contact(up to 24 Hour)
Long Term Contact(more than 1 Days)
EO Residual Testing Segment by Application
Pharmaceuticals
Medical Devices
Food Products
Others
EO Residual Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EO Residual Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of EO Residual Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EO Residual Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of EO Residual Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of EO Residual Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, EO Residual Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Brief Contact(up to 24 Hour)
- Long Term Contact(more than 1 Days)
Applications
- Pharmaceuticals
- Medical Devices
- Food Products
- Others
Companies covered
- Eurofins Scientific
- Nelson Labs
- Steris
- JordiLabs, LLC
- TÜV SÜD
- UFAG LABORATORIEN AG
- Europejski Instytut Biomedyczny
- SaniChem
- Millstone Medical
- Medistri
- Auriga Research
- Pace Analytical
- STEMart
- MCI
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 EO Residual Testing Market by Type
- 1.2.1 Global EO Residual Testing Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Brief Contact(up to 24 Hour)
- 1.2.3 Long Term Contact(more than 1 Days)
- 1.3 EO Residual Testing Market by Application
- 1.3.1 Global EO Residual Testing Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceuticals
- 1.3.3 Medical Devices
- 1.3.4 Food Products
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 EO Residual Testing Market Dynamics
- 2.1 EO Residual Testing Industry Trends
- 2.2 EO Residual Testing Industry Drivers
- 2.3 EO Residual Testing Industry Opportunities and Challenges
- 2.4 EO Residual Testing Industry Restraints
3 Global Growth Perspective
- 3.1 Global EO Residual Testing Market Perspective (2021-2032)
- 3.2 Global EO Residual Testing Growth Trends by Region
- 3.2.1 Global EO Residual Testing Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global EO Residual Testing Market Size by Region (2021-2026)
- 3.2.3 Global EO Residual Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global EO Residual Testing Revenue by Players
- 4.1.1 Global EO Residual Testing Revenue by Players (2021-2026)
- 4.1.2 Global EO Residual Testing Revenue Market Share by Players (2021-2026)
- 4.1.3 Global EO Residual Testing Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global EO Residual Testing Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global EO Residual Testing Key Players Headquarters & Area Served
- 4.4 Global EO Residual Testing Players, Product Type & Application
- 4.5 Global EO Residual Testing Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global EO Residual Testing Market CR5 and HHI
- 4.6.3 2025 EO Residual Testing Tier 1, Tier 2, and Tier 3
5 EO Residual Testing Market Size by Type
- 5.1 Global EO Residual Testing Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global EO Residual Testing Revenue by Type (2021-2032)
- 5.3 Global EO Residual Testing Revenue Market Share by Type (2021-2032)
6 EO Residual Testing Market Size by Application
- 6.1 Global EO Residual Testing Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global EO Residual Testing Revenue by Application (2021-2032)
- 6.3 Global EO Residual Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Eurofins Scientific
- 7.1.1 Eurofins Scientific Company Information
- 7.1.2 Eurofins Scientific Business Overview
- 7.1.3 Eurofins Scientific EO Residual Testing Revenue and Gross Margin (2021-2026)
- 7.1.4 Eurofins Scientific EO Residual Testing Product Portfolio
- 7.1.5 Eurofins Scientific Recent Developments
- 7.2 Nelson Labs
- 7.2.1 Nelson Labs Company Information
- 7.2.2 Nelson Labs Business Overview
- 7.2.3 Nelson Labs EO Residual Testing Revenue and Gross Margin (2021-2026)
- 7.2.4 Nelson Labs EO Residual Testing Product Portfolio
- 7.2.5 Nelson Labs Recent Developments
- 7.3 Steris
- 7.3.1 Steris Company Information
- 7.3.2 Steris Business Overview
- 7.3.3 Steris EO Residual Testing Revenue and Gross Margin (2021-2026)
- 7.3.4 Steris EO Residual Testing Product Portfolio
- 7.3.5 Steris Recent Developments
- 7.4 JordiLabs, LLC
- 7.4.1 JordiLabs, LLC Company Information
- 7.4.2 JordiLabs, LLC Business Overview
- 7.4.3 JordiLabs, LLC EO Residual Testing Revenue and Gross Margin (2021-2026)
- 7.4.4 JordiLabs, LLC EO Residual Testing Product Portfolio
- 7.4.5 JordiLabs, LLC Recent Developments
- 7.5 TÜV SÜD
- 7.5.1 TÜV SÜD Company Information
- 7.5.2 TÜV SÜD Business Overview
- 7.5.3 TÜV SÜD EO Residual Testing Revenue and Gross Margin (2021-2026)
- 7.5.4 TÜV SÜD EO Residual Testing Product Portfolio
- 7.5.5 TÜV SÜD Recent Developments
- 7.6 UFAG LABORATORIEN AG
- 7.6.1 UFAG LABORATORIEN AG Company Information
- 7.6.2 UFAG LABORATORIEN AG Business Overview
- 7.6.3 UFAG LABORATORIEN AG EO Residual Testing Revenue and Gross Margin (2021-2026)
- 7.6.4 UFAG LABORATORIEN AG EO Residual Testing Product Portfolio
- 7.6.5 UFAG LABORATORIEN AG Recent Developments
- 7.7 Europejski Instytut Biomedyczny
- 7.7.1 Europejski Instytut Biomedyczny Company Information
- 7.7.2 Europejski Instytut Biomedyczny Business Overview
- 7.7.3 Europejski Instytut Biomedyczny EO Residual Testing Revenue and Gross Margin (2021-2026)
- 7.7.4 Europejski Instytut Biomedyczny EO Residual Testing Product Portfolio
- 7.7.5 Europejski Instytut Biomedyczny Recent Developments
- 7.8 SaniChem
- 7.8.1 SaniChem Company Information
- 7.8.2 SaniChem Business Overview
- 7.8.3 SaniChem EO Residual Testing Revenue and Gross Margin (2021-2026)
- 7.8.4 SaniChem EO Residual Testing Product Portfolio
- 7.8.5 SaniChem Recent Developments
- 7.9 Millstone Medical
- 7.9.1 Millstone Medical Company Information
- 7.9.2 Millstone Medical Business Overview
- 7.9.3 Millstone Medical EO Residual Testing Revenue and Gross Margin (2021-2026)
- 7.9.4 Millstone Medical EO Residual Testing Product Portfolio
- 7.9.5 Millstone Medical Recent Developments
- 7.10 Medistri
- 7.10.1 Medistri Company Information
- 7.10.2 Medistri Business Overview
- 7.10.3 Medistri EO Residual Testing Revenue and Gross Margin (2021-2026)
- 7.10.4 Medistri EO Residual Testing Product Portfolio
- 7.10.5 Medistri Recent Developments
- 7.11 Auriga Research
- 7.11.1 Auriga Research Company Information
- 7.11.2 Auriga Research Business Overview
- 7.11.3 Auriga Research EO Residual Testing Revenue and Gross Margin (2021-2026)
- 7.11.4 Auriga Research EO Residual Testing Product Portfolio
- 7.11.5 Auriga Research Recent Developments
- 7.12 Pace Analytical
- 7.12.1 Pace Analytical Company Information
- 7.12.2 Pace Analytical Business Overview
- 7.12.3 Pace Analytical EO Residual Testing Revenue and Gross Margin (2021-2026)
- 7.12.4 Pace Analytical EO Residual Testing Product Portfolio
- 7.12.5 Pace Analytical Recent Developments
- 7.13 STEMart
- 7.13.1 STEMart Company Information
- 7.13.2 STEMart Business Overview
- 7.13.3 STEMart EO Residual Testing Revenue and Gross Margin (2021-2026)
- 7.13.4 STEMart EO Residual Testing Product Portfolio
- 7.13.5 STEMart Recent Developments
- 7.14 MCI
- 7.14.1 MCI Company Information
- 7.14.2 MCI Business Overview
- 7.14.3 MCI EO Residual Testing Revenue and Gross Margin (2021-2026)
- 7.14.4 MCI EO Residual Testing Product Portfolio
- 7.14.5 MCI Recent Developments
8 North America
- 8.1 North America EO Residual Testing Revenue (2021-2032)
- 8.2 North America EO Residual Testing Revenue by Type (2021-2032)
- 8.2.1 North America EO Residual Testing Revenue by Type (2021-2026)
- 8.2.2 North America EO Residual Testing Revenue by Type (2027-2032)
- 8.3 North America EO Residual Testing Revenue Share by Type (2021-2032)
- 8.4 North America EO Residual Testing Revenue by Application (2021-2032)
- 8.4.1 North America EO Residual Testing Revenue by Application (2021-2026)
- 8.4.2 North America EO Residual Testing Revenue by Application (2027-2032)
- 8.5 North America EO Residual Testing Revenue Share by Application (2021-2032)
- 8.6 North America EO Residual Testing Revenue by Country
- 8.6.1 North America EO Residual Testing Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America EO Residual Testing Revenue by Country (2021-2026)
- 8.6.3 North America EO Residual Testing Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe EO Residual Testing Revenue (2021-2032)
- 9.2 Europe EO Residual Testing Revenue by Type (2021-2032)
- 9.2.1 Europe EO Residual Testing Revenue by Type (2021-2026)
- 9.2.2 Europe EO Residual Testing Revenue by Type (2027-2032)
- 9.3 Europe EO Residual Testing Revenue Share by Type (2021-2032)
- 9.4 Europe EO Residual Testing Revenue by Application (2021-2032)
- 9.4.1 Europe EO Residual Testing Revenue by Application (2021-2026)
- 9.4.2 Europe EO Residual Testing Revenue by Application (2027-2032)
- 9.5 Europe EO Residual Testing Revenue Share by Application (2021-2032)
- 9.6 Europe EO Residual Testing Revenue by Country
- 9.6.1 Europe EO Residual Testing Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe EO Residual Testing Revenue by Country (2021-2026)
- 9.6.3 Europe EO Residual Testing Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China EO Residual Testing Revenue (2021-2032)
- 10.2 China EO Residual Testing Revenue by Type (2021-2032)
- 10.2.1 China EO Residual Testing Revenue by Type (2021-2026)
- 10.2.2 China EO Residual Testing Revenue by Type (2027-2032)
- 10.3 China EO Residual Testing Revenue Share by Type (2021-2032)
- 10.4 China EO Residual Testing Revenue by Application (2021-2032)
- 10.4.1 China EO Residual Testing Revenue by Application (2021-2026)
- 10.4.2 China EO Residual Testing Revenue by Application (2027-2032)
- 10.5 China EO Residual Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia EO Residual Testing Revenue (2021-2032)
- 11.2 Asia EO Residual Testing Revenue by Type (2021-2032)
- 11.2.1 Asia EO Residual Testing Revenue by Type (2021-2026)
- 11.2.2 Asia EO Residual Testing Revenue by Type (2027-2032)
- 11.3 Asia EO Residual Testing Revenue Share by Type (2021-2032)
- 11.4 Asia EO Residual Testing Revenue by Application (2021-2032)
- 11.4.1 Asia EO Residual Testing Revenue by Application (2021-2026)
- 11.4.2 Asia EO Residual Testing Revenue by Application (2027-2032)
- 11.5 Asia EO Residual Testing Revenue Share by Application (2021-2032)
- 11.6 Asia EO Residual Testing Revenue by Country
- 11.6.1 Asia EO Residual Testing Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia EO Residual Testing Revenue by Country (2021-2026)
- 11.6.3 Asia EO Residual Testing Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA EO Residual Testing Revenue (2021-2032)
- 12.2 SAMEA EO Residual Testing Revenue by Type (2021-2032)
- 12.2.1 SAMEA EO Residual Testing Revenue by Type (2021-2026)
- 12.2.2 SAMEA EO Residual Testing Revenue by Type (2027-2032)
- 12.3 SAMEA EO Residual Testing Revenue Share by Type (2021-2032)
- 12.4 SAMEA EO Residual Testing Revenue by Application (2021-2032)
- 12.4.1 SAMEA EO Residual Testing Revenue by Application (2021-2026)
- 12.4.2 SAMEA EO Residual Testing Revenue by Application (2027-2032)
- 12.5 SAMEA EO Residual Testing Revenue Share by Application (2021-2032)
- 12.6 SAMEA EO Residual Testing Revenue by Country
- 12.6.1 SAMEA EO Residual Testing Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA EO Residual Testing Revenue by Country (2021-2026)
- 12.6.3 SAMEA EO Residual Testing Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst